Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to presentation in connection with EQL Pharma's quarterly report, second quarter, 2023/24

EQL Pharma AB (publ) will publish its quarterly report for the second quarter, 2023/24, on Friday, November 17[th], before stock markets opening.At 10.00 (CET) 17[th] November, the company will give a presentation via video conference. The presentation is aimed at shareholders and potential shareholders. CEO and President Axel Schörling presents and comments on the quarterly report. After the presentation, there is an opportunity to ask questions for those who participate. Use the following link to access the virtual meeting: https://tinyurl.com/mpzed7uf  Date and time November 17[

Swedavia announces tender offer for certain outstanding SEK capital securities

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT.Swedavia AB (publ) (the "Issuer") is offering holders of the Issuer's outstanding capital securitiesoutlinedbelow (the "Securities") to tender any and all of their Securities for purchase by the Issuer for cash (the "Tender Offer") at the price set out below. Securities will be repurchased subject to the

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 189 - 6 NOVEMBER 2023 In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Fiskars Group publishes a Sustainability-Linked Bond Framework

Fiskars Corporation Press release November 6, 2023 at 10:05 EET  Fiskars Group publishes a Sustainability-Linked Bond Framework  Fiskars Group has launched a Sustainability-Linked Bond Framework with the aim to align the company’s long-term financing strategy with its sustainability targets. The financial characteristics of the notes are linked to the achievement of two environmental targets, namely reducing GHG emissions from Fiskars Group's own operations (scope 1 and 2) and percentage of suppliers by spend with set science-based emission reduction targets (scope 3). “Fiskars

Inify Laboratories receives accreditation as a medical laboratory

STOCKHOLM - November 6, 2023 - Inify Laboratories, a unique laboratory service that provides cancer diagnostics in pathology, has received accreditation as a medical laboratory according to the ISO 15189 standard.   "To be accredited within five months of launching a completely unique laboratory service for cancer diagnostics must be some kind of record. It is yet another confirmation of the ability, quality awareness, and breadth of knowledge that Inify possesses," says Fredrik Palm, CEO of Inify Laboratories.   "For Inify, this is proof that our business lives up to the high

Admission to Trading

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, OR JAPAN.     6 November 2023     Everest Global Plc   Admission to Trading     Further to its announcement dated 31 October 2023, Everest Global Plc is pleased to announce that the Allotted Shares will today be admitted to the Official List of the FCA (Standard Listing Segment) and to trading on the Main Market for listed securities of the London Stock Exchange. Dealing in the Allotted Shares will

Södra and Lenzing receive international cooperation award

On November 6, 2023 Södra and its collaboration partner Lenzing Group received the International Textile Manufacturers Federation (ITMF) Award 2023 in the category "International Cooperation" for their joint achievements in textile recycling and circular economy.The International Textile Manufacturers Federation (ITMF), honours outstanding achievements and merits in the textile sector in two categories: "Sustainability & Innovation" and "International Cooperation". The two companies have been collaborating on developing wood-based textile pulp since 2011 and joined forces in textile

Purmo Group in 7-year agreement with H2 Green Steel for near zero emission steel supply

Purmo Group, a leader in sustainable indoor climate comfort solutions, has entered into a binding agreement with H2 Green Steel, for the delivery of 140,000 tonnes of green steel during 2026-2033.The deliveries will support Purmo Group in its further advancement in sustainability. Steel represents approximately 50% of all raw material purchases in the Group.  “This is an excellent collaboration with H2 Green Steel and another milestone in our sustainability journey towards carbon neutrality. With this agreement, we will be pioneers in our industry, securing the supply of green steel and

Metsä Group and Quant Finland agree on a common goal to reduce fossil oil consumption

Metsä Group and industrial maintenance service provider Quant Finland have agreed to halve the consumption of fossil hydraulic oil together in Metsä Group's plywood and Kerto LVL mills by 2027 compared to 2022. Quant is Metsä Group's maintenance service partner at its Kerto LVL and plywood mills located in Lohja, Punkaharju, Suolahti, Äänekoski and Pärnu. Hydraulic oil is widely used in production machinery and equipment. Oil consumption can be reduced through close monitoring, systematic maintenance and investments. Large industrial players have significant potential to reduce the

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions 6 November 2023 at 10.00 a.m. EETBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Timo Lehtonen Position: Chief Executive Officer  Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 42517/5/4   ____________________________________________ Transaction date: 2023-11-01 Outside a trading venue Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN:

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions 6 November 2023 at 10.00 a.m. EETBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Rami Ojala Position: Other senior manager  Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 42518/5/4 ____________________________________________ Transaction date: 2023-11-01 Outside a trading venue Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN:

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions 6 November 2023 at 10.00 a.m. EETBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Esa Hallinen Position: Other senior manager  Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 42520/5/4   ____________________________________________ Transaction date: 2023-11-03 Outside a trading venue Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN:

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions 6 November 2023 at 10.00 a.m. EETBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Mari Ruotsalainen Position: Other senior manager  Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 42526/5/4   ____________________________________________ Transaction date: 2023-11-01 Outside a trading venue Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT ISIN:

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions 6 November 2023 at 10.00 p.m. EETBioretec Oy - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Minna Ahlstedt-Soini Position: Other senior manager  Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 42529/4/4   ____________________________________________ Transaction date: 2023-11-03 Outside a trading venue Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT

Bergans of Norway signs with Ingrid

Believe in tomorrow — explore today. We're proud to welcome Bergans of Norway as our client! Bergans of Norway makes premium quality outdoor products in a more sustainable way, trusted and loved by the Norwegians since 1908. They've got everything to give each customer the best possible wilderness experience, regardless of the weather and conditions. Together, we embark on providing a seamless delivery experience for every nature enthusiast out there. Soon, Bergans of Norway's shoppers will have access to the best, contextually-tailored delivery options — including delivery

XNK Therapeutics announces poster presentations at the 38[th] Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

XNK Therapeutics AB (”XNK”) participates in the SITC meeting, which takes place in San Diego, USA, and will present the latest research relating to the company’s leading natural killer (NK) cell therapies. Two abstracts have been accepted for presentation at the meeting.The first poster, titled Harnessing the Potential of Autologous NK Cells for Immune Therapy of Patients with Advanced Bladder Cancer, describes the successful expansion of autologous NK cells from peripheral blood mononuclear cells (PBMCs) from bladder cancer patients. Results demonstrate that NK cells from patients before

Carbiotix completes phase one of CarbiAXOS production upgrade in Bjuv

Carbiotix (publ) ("Carbiotix" or the "Company") announces today that the Company has completed phase one of the CarbiAXOS production upgrade at the Company’s production site in Bjuv, Sweden. The upgrade involved the commissioning of a production tank and filtration system to produce Carbiotix’ second generation CarbiAXOS prebiotic ingredient. The Company anticipates that phase two of the production upgrade will be completed in early Q1 2024, allowing the Company to have full control of its production process and accelerate development activities.Carbiotix announces today the successful

Fiskars Group considers issuance of sustainability-linked notes

Fiskars CorporationStock exchange releaseNovember 6, 2023 at 9.45 a.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Fiskars Group considers issuance of sustainability-linked notes Fiskars Group is considering an issuance of its inaugural euro-denominated senior unsecured sustainability-linked notes with an expected principal amount

Repurchase of Truecaller B shares in week 44, 2023

During 30 October 2023 and 3 November 2023 Truecaller AB (publ) (LEI code 549300TEYF1FA5G5GK26) has repurchased in total 1,340,000 own B shares (ISIN: SE0016787071) as part of the share buyback programme initiated by the board of directors.The share buybacks form part of the share buyback programme announced by Truecaller on 7 June 2023. The share buyback programme will run between 7 June up until the 2024 AGM which will be held in May 2024, and is carried out in accordance “Emittentregelverket”. On the Annual General Meeting 2023 the Board was authorized to buy back B-shares up until

Buybacks of shares in ITAB during week 44 2023

During the period between 30 October and 3 November 2023, ITAB Shop Concept AB (publ) (”ITAB”) (LEI-code: 2138001H6FCSZBP26351) has repurchased in total 31,192 own ordinary shares (ISIN: SE0015962097) as part of the share buyback program initiated by the Board of Directors in order to optimise the capital structure.The share buybacks form part of the share buyback program in a maximum amount of MSEK 50 that ITAB announced on 28 September 2023. The share buyback program, which runs from 29 September 2023 until 14 May 2024, is being carried out in accordance with the EU Market Abuse

CHROMOGENICS AB: TODAY IS THE START OF THE EXERCISE PERIOD FOR WARRANTS OF SERIES TO 6 IN CHROMOGENICS. THE SUBSCRIPTION PRICE HAS BEEN SET AT SEK 8.51

Today, 6 November 2023, the exercise period begins for the warrants of series TO 6 (the "Warrants"), which were issued in connection with ChromoGenics AB's ("ChromoGenics" or the "Company") rights issue of units announced on 17 May 2023 (the "Rights Issue"). Note that Warrants not sold by 15 November 2023, or alternatively exercised to subscribe for shares no later than 20 November 2023, expire without value. In connection with the Rights Issue, ChromoGenics issued 240,222,962 Warrants. The exercise period of the Warrants runs from and including today, 6 November 2023, until and

Issue and repurchase of class C shares for incentive program

The board of directors for Medicover AB (publ) has today resolved to issue 1,600,000 new class C shares and to immediately thereafter repurchase such 1,600,000 issued class C shares, for the purpose of the long term performance-based share programs for key individuals as approved by the annual general meetings held on 29 April 2021, 27 April 2022 and 27 April 2023 (the “Plan 2021”, the “Plan 2022” and the “Plan 2023”). Today’s resolution by the board of directors was passed based on the authorisation granted by the annual general meeting held on 27 April 2023. Nordea Bank Abp will

Information from the principal owners: Proposal for a new Chairman in Embellence Group AB

A number of the largest shareholders* (Major Shareholders) in Embellence Group AB have today informed the board of directors that they intend to propose a new Chairman of the board to be elected at an extraordinary general meeting as soon as practically possible. Invitation to this will be sent out shortly.Magnus Welander will be proposed as new Chairman of the board. In connection with this publication, Magnus Welander has also entered into an agreement for the acquisition of 210,305 shares in the company. These shares are sold from the main owners pro rata to each owner's holdings. The

Finland’s first quantum computer opened for companies

VTT Technical Research Centre of Finland has opened its 5-qubit quantum computer for Finnish and European companies, enabling them to develop quantum algorithms and software and assess their suitability for solving practical computational problems. The quantum computer is accessed through the LUMI supercomputer, which is located in CSC data center in Kajaani, Finland.Quantum computers and quantum computing will revolutionise many sectors. Finnish and European companies can now have access to a Finnish quantum computer based on superconductive technology by paying a fixed monthly fee. It

There are no items matching the current filter
There are no more items matching the current filter
Back to top